Home » Topics » Infection, BioWorld Science

Infection, BioWorld Science
RSS

High priority given to linezolid development at Pharmacia & Upjohn

May 12, 1998

BCX-140, an aromatic inhibitor of influenza neuraminidase

May 12, 1998

Sequus and Faulding sign marketing agreement for Amphotec

May 12, 1998

Cubist and Merck & Co. expand antiinfective drug discovery agreement

May 11, 1998

BioFocus and Cubist form antiinfectives alliance

May 11, 1998

Bayer fluoroquinoline is effective against murine tuberculosis

May 7, 1998

Advisory committee recommends FDA approval for TB treatment

May 6, 1998

Pharmacological profile of Otsuka's OPB-2045

May 6, 1998

Sumitomo claims beta-lactams active against resistant staphylococci

May 5, 1998

Takeda developing carbapenems for Gram-negative infections

May 5, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...